-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Blood Advances Presents: How to Peer Review a Scientific Paper

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Sunday, December 11, 2022: 11:15 AM-12:15 PM
252-254 (Ernest N. Morial Convention Center)
Leslie S. Kean, MD, PhD, Boston Children's Hospital, Harvard Medical School and Andrew S. Weyrich, PhD, Oklahoma Medical Research Foundation
Kean: Bristol Myers Squibb: Patents & Royalties: clinical trial, Research Funding; Magenta: Research Funding; Novartis: Research Funding; Bluebird Bio: Research Funding; Vertex: Consultancy; EMD-Serono: Research Funding; Mammoth Biosciences: Current equity holder in private company, Current holder of stock options in a privately-held company; HiFiBio: Consultancy.